Pediatric Deaths Associated With Coronavirus Disease 2019 (COVID-19) in Korea

Eunjeong Shin1, Young June Choe2, Boyeong Ryu1

  • 1Data Analysis Team, Epidemiological Investigation and Analysis Task Force, Central Disease Control Headquarters, Korea Disease Control and Prevention Agency, Cheongju, Korea.

Insights

In Korea, over 5.3 million child COVID-19 cases were reported by September 2022, with 46 deaths. Most child fatalities occurred early after diagnosis, highlighting the need for accessible medical care.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) has impacted global populations, including children.
  • Understanding pediatric COVID-19 mortality patterns is crucial for public health strategies.

Purpose of the Study:

  • To analyze the characteristics and outcomes of COVID-19 associated deaths in children in Korea.
  • To identify risk factors and timing of death in pediatric COVID-19 cases.

Main Methods:

  • Retrospective analysis of reported COVID-19 cases and deaths in children (≤ 18 years) in Korea up to September 3, 2022.
  • Examination of demographic data, underlying conditions, immunization status, and time from diagnosis to death for fatal cases.

Main Results:

  • A total of 5,388,338 COVID-19 cases and 46 deaths were reported in children. The case fatality rate was 0.85 per 100,000.
  • Among the 46 deaths, the median age was 7 years, and 58.7% were male. Underlying diseases were present in 47.8%, with neurologic diseases being most common.
  • Deaths often occurred rapidly after diagnosis (median 2 days), with a significant proportion occurring before or upon hospital arrival. Myocarditis and respiratory failure were common documented causes.

Conclusions:

  • COVID-19 associated deaths in children can occur very early after diagnosis.
  • The findings underscore the critical need for accessible and timely medical interventions for pediatric COVID-19 patients.
  • Public health policies must prioritize ensuring prompt access to healthcare for children during pandemics.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
277
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
181
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
260
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
344
Health Hazards of Air Pollution01:20

Health Hazards of Air Pollution

Health Hazards of Air PollutionAir pollution doesn’t just harm the environment; it can also profoundly affect human health. Breathing polluted air can cause problems like asthma, allergies, lung diseases, and even heart conditions. Tiny particles, harmful gases like carbon monoxide, sulfur dioxide, nitrogen oxides, or chemicals from vehicles and factories can enter our lungs and bloodstream. Both outdoor and indoor air pollution can impact people, especially children, the elderly, and those...
1